FIBROGEN INC - Common Stock, $0.01 par value (FGEN)

Historical Holders from Q4 2014 to Q3 2025

Symbol
FGEN on Nasdaq
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
101M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of FIBROGEN INC - Common Stock, $0.01 par value (FGEN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 8.42% +23.9% $2.81M $561K 8.5M +25% Armistice Capital, LLC 31 Mar 2025
PRIMECAP MANAGEMENT CO/CA/ 4.58% $1.52M 4.62M PRIMECAP MANAGEMENT CO/CA/ 31 Dec 2024

Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$79.5K 0
2025 Q2 15K $79.5K -$10.1M $5.30 1
2025 Q1 33M $10.2M -$1.81M $0.31 52
2024 Q4 36.3M $19.2M -$4.58M $0.53 65
2024 Q3 45.9M $18.9M -$6.43M $0.40 68
2024 Q2 56.5M $50.4M -$9.08M $0.89 100
2024 Q1 61.2M $144M -$18.9M $2.35 106
2023 Q4 70.1M $62.1M +$1.48M $0.89 99
2023 Q3 68.3M $58.9M -$26.3M $0.86 106
2023 Q2 76.3M $206M -$161M $2.70 149
2023 Q1 76.4M $1.42B +$29M $18.66 171
2022 Q4 74.9M $1.2B +$34.8M $16.02 143
2022 Q3 73.1M $950M +$31.4M $13.01 146
2022 Q2 70.7M $747M +$29.4M $10.56 145
2022 Q1 67.9M $817M +$18.1M $12.02 150
2021 Q4 66.3M $935M +$30.5M $14.10 157
2021 Q3 64.1M $654M -$173M $10.22 156
2021 Q2 67.7M $1.8B -$97.2M $26.63 170
2021 Q1 71.2M $2.47B -$31.5M $34.71 190
2020 Q4 72M $2.67B +$83.6M $37.09 202
2020 Q3 68.9M $2.84B +$69.1M $41.12 205
2020 Q2 67.3M $2.73B +$110M $40.53 188
2020 Q1 64.5M $2.24B +$113M $34.75 183
2019 Q4 61.4M $2.63B +$38.7M $42.89 208
2019 Q3 60.8M $2.25B -$21.6M $36.98 207
2019 Q2 61.3M $2.77B +$156M $45.18 188
2019 Q1 57.9M $3.15B +$65M $54.35 221
2018 Q4 56.8M $2.63B -$106M $46.28 193
2018 Q3 55.9M $3.39B -$20.6M $60.75 184
2018 Q2 56.2M $3.52B +$182M $62.60 191
2018 Q1 53.3M $2.46B +$130M $46.20 191
2017 Q4 50.2M $2.38B +$98.5M $47.40 184
2017 Q3 47.9M $2.58B +$551M $53.80 178
2017 Q2 37.9M $1.22B +$270M $32.30 148
2017 Q1 31.1M $766M +$133M $24.65 141
2016 Q4 30.2M $645M -$11.8M $21.40 135
2016 Q3 30.8M $637M -$11.9M $20.70 130
2016 Q2 31.6M $518M -$37.2M $16.41 142
2016 Q1 32.9M $699M +$21.6M $21.29 133
2015 Q4 31.6M $963M +$96.2M $30.47 134
2015 Q3 28.6M $626M +$76.7M $21.92 114
2015 Q2 24.2M $569M +$191M $23.50 93
2015 Q1 15.2M $470M +$11.9M $31.38 74
2014 Q4 14.8M $400M +$389M $27.34 65